Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Optimizing Treatment on Idiopathic Inflammatory Myopathies
Brief Summary:
As a T2T, our patients with idiopathic inflammatory myopathies will receive pulse therapies with methyprednisolone and/or human intravenous immunoglobulin, or only methyprednisolone at disease onset.
This scheme is an internal routine protocol of our Service.